This literature review illustrates the possibilities of GPCR monitoring with HTRF second messenger cAMP and IP-1 assays in a cardiovascular context. It features experiments and data from published studies that investigated b-arrestin-biased ligands of the angiotensin II and apelin receptors, as well as inhibitor screening of the relaxin receptor and atrial natriuretic peptide signaling through ANPRs.
Features
We are committed to your privacy. Revvity needs the contact information you provide us to keep you aware about relevant content, products, and services. You may unsubscribe from these communications at any time. For more information check out our Privacy Policy.
©2024 Revvity - All rights reserved